Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.

Arlt VM, Stiborova M, Schmeiser HH.

Mutagenesis. 2002 Jul;17(4):265-77. Review.

PMID:
12110620
2.

Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.

Schmeiser HH, Nortier JL, Singh R, Gamboa da Costa G, Sennesael J, Cassuto-Viguier E, Ambrosetti D, Rorive S, Pozdzik A, Phillips DH, Stiborova M, Arlt VM.

Int J Cancer. 2014 Jul 15;135(2):502-7.

PMID:
24921086
3.

32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.

Bieler CA, Stiborova M, Wiessler M, Cosyns JP, van Ypersele de Strihou C, Schmeiser HH.

Carcinogenesis. 1997 May;18(5):1063-7.

PMID:
9163697
4.

The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.

Stiborova M, Frei E, Arlt VM, Schmeiser HH.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):5-11. Review.

5.

Chemical and molecular basis of the carcinogenicity of Aristolochia plants.

Schmeiser HH, Stiborovà M, Arlt VM.

Curr Opin Drug Discov Devel. 2009 Jan;12(1):141-8. Review.

PMID:
19152223
7.
8.

Aristolochic acid nephropathy: a worldwide problem.

Debelle FD, Vanherweghem JL, Nortier JL.

Kidney Int. 2008 Jul;74(2):158-69. doi: 10.1038/ki.2008.129. Epub 2008 Apr 16. Review.

9.

Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.

Stiborová M, Frei E, Sopko B, Wiessler M, Schmeiser HH.

Carcinogenesis. 2002 Apr;23(4):617-25.

PMID:
11960915
10.

Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.

Xing G, Qi X, Chen M, Wu Y, Yao J, Gong L, Nohmi T, Luan Y, Ren J.

Mutat Res. 2012 Mar 18;743(1-2):52-8. doi: 10.1016/j.mrgentox.2011.12.021. Epub 2012 Jan 5.

PMID:
22245565
11.
12.

Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.

Arlt VM, Wiessler M, Schmeiser HH.

Carcinogenesis. 2000 Feb;21(2):235-42.

PMID:
10657963
13.
14.

Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.

Arlt VM, Meinl W, Florian S, Nagy E, Barta F, Thomann M, Mrizova I, Krais AM, Liu M, Richards M, Mirza A, Kopka K, Phillips DH, Glatt H, Stiborova M, Schmeiser HH.

Arch Toxicol. 2017 Apr;91(4):1957-1975. doi: 10.1007/s00204-016-1808-6. Epub 2016 Aug 24.

15.

Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.

Martinek V, Kubickova B, Arlt VM, Frei E, Schmeiser HH, Hudecek J, Stiborova M.

Neuro Endocrinol Lett. 2011;32 Suppl 1:57-70.

PMID:
22167209
16.
18.

Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.

Stiborová M, Frei E, Breuer A, Wiessler M, Schmeiser HH.

Mutat Res. 2001 Jun 27;493(1-2):149-60.

PMID:
11516724
19.

Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.

Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH.

Carcinogenesis. 2007 Nov;28(11):2253-61. Epub 2007 Apr 13. Review.

PMID:
17434925
20.

Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.

Stiborová M, Frei E, Breuer A, Bieler CA, Schmeiser HH.

Exp Toxicol Pathol. 1999 Jul;51(4-5):421-7.

PMID:
10445409

Supplemental Content

Support Center